$BIO News

Is Elliott’s Sartorius Push Altering The Investment Case For Bio-Rad Laboratories (BIO)?

Elliott Targets Bio-Rad After 70% Stock Collapse

Why Elliott Sees Hidden Billions Inside Bio-Rad Laboratories

'Activist Elliott Builds Big Stake in Life-Science Tools Supplier Bio-Rad' - WSJ

RBC Capital Reinstates Outperform on Bio-Rad Laboratories, Announces $320 Price Target

Bio-Rad to Participate in Upcoming Investor Conferences

Ariel Investments Re-added Bio-Rad Laboratories (BIO) as Strong Margins and Market Leadership Stand Out

Bio-Rad (BIO) Q2 2025 Earnings Call Transcript

Unlocking Bio-Rad (BIO) International Revenues: Trends, Surprises, and Prospects

Bio-Rad (BIO) Q1 2026 Earnings Transcript

Bio-Rad Laboratories, Inc. Q1 2026 Earnings Call Summary

Wells Fargo Maintains Equal-Weight on Bio-Rad Laboratories, Lowers Price Target to $290

Bio-Rad Laboratories Inc (BIO) Q1 2026 Earnings Call Highlights: Navigating Challenges with ...

Bio-Rad Laboratories Q1 Earnings Call Highlights

Bio-Rad Q1 2026 Revenue Misses Estimates, Outlook Cut as NYSE:BIO Faces Cautious Trading

Bio-Rad Laboratories (BIO) Lags Q1 Earnings Estimates

Bio-Rad Reports First-Quarter 2026 Financial Results

Bio-Rad Laboratories Lowers FY2026 Sales Guidance from $2.596B-$2.622B to $2.506B-$2.596B vs $2.630B Est

Transcript: Bio-Rad Laboratories Q1 2026 Earnings Conference Call

Bio-Rad Laboratories Q1 Adj. EPS $1.89 Misses $1.98 Estimate, Sales $592.100M Beat $588.875M Estimate